Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
1.800
-0.220 (-10.89%)
At close: Jun 17, 2025, 4:00 PM
1.840
+0.040 (2.22%)
After-hours: Jun 17, 2025, 7:15 PM EDT

Artiva Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
44245----
Upgrade
Enterprise Value
-108113----
Upgrade
Last Close Price
1.8010.08----
Upgrade
Debt / Equity Ratio
0.080.080.310.260.010.13
Upgrade
Asset Turnover
-0.000.280.030.02-
Upgrade
Quick Ratio
13.6215.226.454.028.364.41
Upgrade
Current Ratio
13.9315.406.534.098.414.53
Upgrade
Return on Equity (ROE)
-68.14%-54.24%-44.15%-57.84%-99.72%-286.85%
Upgrade
Return on Assets (ROA)
-33.30%-26.72%-16.10%-24.68%-33.43%-67.03%
Upgrade
Return on Capital (ROIC)
-38.92%-30.89%-23.03%-33.32%-45.02%-101.60%
Upgrade
Buyback Yield / Dilution
-2024.91%-1302.54%-4.70%-11.80%-8.60%-3.59%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q